Word

PAIONEER

Status

Dead

Status Code

710

Status Date

Friday, August 12, 2016

Serial Number

78506558

Registration Number

3734289

Registration Date

Tuesday, January 5, 2010

Mark Type

4000

Filing Date

Wednesday, October 27, 2004

Published for Opposition

Tuesday, July 15, 2008

Cancellation Date

Friday, August 12, 2016

Trademark Owner History

PAION DEUTSCHLAND GMBH - Original Registrant
Paion GmbH - Original Applicant

Classifications

1 Reagents for scientific or medical research use; diagnostic reagents for scientific or research use, biochemical reagents for scientific or medical research use; reagents for scientific or research use, none of the foregoing goods for use in the agricultural industry, including biopharming

5 Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use, none of the foregoing goods for use in the agricultural industry, including biopharming

35 Computerized database management, namely, editing, evaluating and processing data for third parties

41 Educational services, namely, providing informational events in the nature of seminars and workshops in the fields of pharmacology, medical procedures, product research and development of medical devices and pharmaceutical preparations, none of the foregoing services offered to the agricultural industry, including biopharming

42 Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; preparation of expert opinions in the field biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment. scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment, none of the foregoing services offered to the agricultural industry, including biopharming

Trademark Events

Aug 12, 2016

Cancelled Sec. 8 (6-Yr)

Jan 5, 2010

Registered-Principal Register

Jan 4, 2010

Assigned To Examiner

Dec 1, 2009

Ttab Release Case To Trademarks

Dec 1, 2009

Opposition Terminated No. 999999

Dec 1, 2009

Opposition Dismissed No. 999999

Jan 15, 2009

Opposition Instituted No. 999999

Nov 7, 2008

Reg. Cancelled - Restored To Pendency

Oct 31, 2008

Assigned To Petition Staff

Oct 10, 2008

Request To Cancel Inadvertently Issued Registration Received

Sep 30, 2008

Registered-Principal Register

Aug 14, 2008

Extension Of Time To Oppose Process - Terminated

Aug 14, 2008

Extension Of Time To Oppose Received

Jul 15, 2008

Published For Opposition

Jun 25, 2008

Notice Of Publication

Jun 6, 2008

Law Office Publication Review Completed

Jun 3, 2008

Approved For Pub - Principal Register

Jun 3, 2008

Amendment From Applicant Entered

Apr 11, 2008

Correspondence Received In Law Office

Jun 3, 2008

Examiner's Amendment Entered

Jun 2, 2008

Assigned To Lie

Jun 2, 2008

Notification Of Examiners Amendment E-Mailed

Jun 2, 2008

Examiners Amendment E-Mailed

Jun 2, 2008

Examiners Amendment -Written

Jun 2, 2008

Previous Allowance Count Withdrawn

Jun 2, 2008

1(B) Basis Deleted; New Basis Requested

Jun 2, 2008

Notice Of Allowance Cancelled

Apr 18, 2008

Extension 4 Granted

Apr 18, 2008

Extension 4 Filed

Apr 18, 2008

Teas Extension Received

Apr 16, 2008

Attorney Review/Decision On Amendment Required

Apr 16, 2008

Petition To Director - Change Basis - Granted

Apr 16, 2008

Assigned To Petition Staff

Apr 11, 2008

Petition To Director - Change Basis - Received

Apr 11, 2008

Paper Received

Oct 22, 2007

Extension 3 Granted

Oct 22, 2007

Extension 3 Filed

Oct 22, 2007

Teas Extension Received

Jul 27, 2007

Extension 2 Granted

Apr 18, 2007

Extension 2 Filed

Apr 18, 2007

Teas Extension Received

Oct 11, 2006

Extension 1 Granted

Oct 11, 2006

Extension 1 Filed

Oct 11, 2006

Teas Extension Received

Apr 25, 2006

Noa Mailed - Sou Required From Applicant

Mar 4, 2006

Extension Of Time To Oppose Process - Terminated

Oct 25, 2005

Amendment From Applicant Entered

Oct 25, 2005

Paper Received

Oct 20, 2005

Extension Of Time To Oppose Received

Oct 4, 2005

Published For Opposition

Sep 14, 2005

Notice Of Publication

Aug 12, 2005

Law Office Publication Review Completed

Aug 10, 2005

Assigned To Lie

Aug 2, 2005

Approved For Pub - Principal Register

Aug 2, 2005

Amendment From Applicant Entered

Jul 27, 2005

Correspondence Received In Law Office

Jul 27, 2005

Paper Received

Jun 2, 2005

Non-Final Action E-Mailed

Jun 2, 2005

Non-Final Action Written

Jun 2, 2005

Assigned To Examiner

Nov 5, 2004

New Application Entered In Tram